Table 2.
Univariate and multivariate analysis of overall survival in 63 patients with locally advanced stage III cervical esophageal squamous cell carcinoma who received curative concurrent chemoradiotherapy.
| Characteristics | No. of Patients | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|---|
| Median OS (Months) | p-Value | HR (95% CI) | p-Value | ||
| Age (years) | |||||
| <60 years | 37 (59%) | 21.6 | 0.44 | ||
| ≥60 years | 26 (41%) | 12.0 | |||
| T status | |||||
| 2 + 3 + 4a | 19 (30%) | 26.1 | 0.035 * | 0.47 (0.23–0.98) | 0.044 * |
| 4b | 44 (70%) | 17.3 | |||
| N status | |||||
| 0 + 1 | 29 (46%) | 21.6 | 0.54 | ||
| 2 + 3 | 34 (54%) | 19.1 | |||
| Tumor stage | |||||
| IIIA + IIIB | 12 (19%) | 25.3 | 0.56 | ||
| IIIC | 51 (81%) | 21.0 | |||
| Grade | |||||
| 1 + 2 | 50 (79%) | 22.2 | 0.015 * | 0.42 (0.20–0.89) | 0.023 * |
| 3 | 13 (21%) | 11.3 | |||
OS, overall survival; HR, hazard ratio; CI, confidence interval; * statistically significant.